About this Research Topic
In this Research Topic, we would like to create a forum for current advances on epigenetic regulation in cardiovascular disease (CVD), especially cardiac remodeling and vascular diseases. As we know, epigenetic mechanisms involve in almost all pathological and physiological processes of the body, such as organ development, cell proliferation and differentiation, aging, cell death. Although there have been researches on the role of epigenetic regulation in cardiovascular disease, a comprehensive understand remains undisclosed. More importantly, development of epigenetic regulation related drugs, for clinical use in safety and efficacy, is of crucial and urgent needs.
Suggested paper themes include:
1) Epigenetic mechanisms: post-translational histone modifications, DNA methylation and noncoding RNAs.
2) DNA methylation in cardiac remodeling and vascular diseases.
3) Post-translational histone modifications in cardiac remodeling and vascular diseases: histone acetylation in cardiac remodeling and vascular diseases, HDACs inhibitors in cardiac remodeling and vascular diseases, histone phosphorylation in cardiac remodeling and vascular diseases, histone ubiquitination in cardiac remodeling and vascular diseases, histone methylation in cardiac remodeling and vascular diseases, the inhibitors of methyltransferases in cardiac remodeling and vascular diseases.
4) RNA-based epigenetics in cardiac remodeling and vascular diseases: noncoding RNAs in cardiac remodeling and vascular diseases.
Keywords: Aortic dissection/aneurysm, Atherosclerosis, Pulmonary arterial hypertension, Epigenetics, Histone methylation, Histone acetylation, DNA methylation, noncoding RNAs, Cardiac remodeling
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.